3656 results for «310»
3656 results
EuroPCR 2022 Hotlines / Late-Breaking Trials in TAVI: TRANSIT-PPM, LYTEN, SCOPE 2, and more!
18 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in TAVI! Balloon vs. self-expanding valves in valve-in-valve TAVI, trilogy for treatment of aortic regurgitation, management of Myocardial Revascularization in Patients with Stable Coronary Artery Disease Undergoing TAVI, SCOPE 2 subanalysis, prosthesis-patient mismatch following TAVR, and stroke complicating...
PCR Innovators Day - Jon DeHaan Award winner announcement
19 May 2022 – From EuroPCR 2022
After a look back at the winners of previous editions, find out who the finalists are for 2022 before the suspense is lifted and the winners are finally revealed.
PCR Innovators Day - Machine learning and artificial intelligence
19 May 2022 – From EuroPCR 2022
Learn more about machine learning and artificial intelligence for automated assessment of CAD, risk assessment and early patient stratification, continuous monitoring of cardiac performance, and much more!
EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in drug-eluting balloons! A Sirolimus-coated balloon with micro-reservoir technology in coronary lesions, utilisation of DEB guided by post-PCI pressure gradient, DEB in combination with DES in the treatment of diffuse coronary artery disease,DEB for in-stent restenosis and plaque...
PCR Innovators Day - Follow-up and technology updates
19 May 2022 – From EuroPCR 2022
In this EuroPCR 2022 session, find out more about how mastering heart failure treatment by empowering physicians and patients, discover a novel approach for fluid removal, an adjustable interatrial shunt system, and much more!
Multimodality assessment of coronary artery disease
18 May 2022 – From EuroPCR 2022
Watch these videos to learn more about the use of multimodality imagery to assess coronary artery disease (CAD), such as coronary artery anomalies (CAAs), ischemic and non-ischemic cardiomyopathy, obstructive CAD in heart failure patients, and more!
Innovative coronary approches for your daily practice
20 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session presents innovative types of coronary approches used in different Clinical Case submissions: severe calcific tortuous LAD disease, the calcium challenge or IVUS-guided CTO PCI with minimum contrast...
Treatment of small vessel disease - To stent or not to stent?
07 Oct 2022 – From AICT-AsiaPCR 2022
Consult this session if you want to learn the tips and tricks to perform a small vessel disease intervention and to discuss the pros and cons of treating small vessel disease with DCB and/or DES.
SEISMIC-HF I - Exploring non-invasive methods for monitoring intracardiac filling pressures
16 Nov 2024
Luis Ortega provides his take on the SEISMIC-HF I study presented by Liviu Klein at AHA 2024, in Chicago.
Author
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.
Author
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events
01 Sep 2022
Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
Coronary OCT and CMR imaging to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries
29 Mar 2026
Nicola Ryan provides her take on the trial evaluating multi-modality imaging to determine underlying causes of MINOCA in women and men. The trial results were presented by Harmony R. Reynolds at ACC.26 in New Orleans and simultaneously published in Circulation.
Author
UNIVERSAL: routine ultrasonography guidance for femoral vascular access for cardiac procedures - A randomized clinical Trial
19 Sep 2022
Ali Nazmi Calik provides his take on UNIVERSAL randomized clinical trial, which questioned whether routine ultrasonography guidance for CFA access for cardiac procedures reduces bleeding or vascular complications. This trial was presented by Sanjit S. Jolly during TCT 2022.
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
